Cost-effectiveness of different caries preventive measures in a high-risk population of Swedish adolescents.
A total of 3373 12-year-olds agreed to participate in an intervention study evaluating different caries preventive measures. The study, titled 'Evaluation of caries preventive measures', was performed between 1995 and 1999 at 26 dental health clinics throughout Sweden. At the start of the study, the subjects were classified as individuals at high or low risk of developing caries. The high-risk group consisted of 1165 subjects. The children in the high-risk group were randomly assigned to one of four preventive programs. The programs represent a step-wise increase in fluoride content, contact with dental personnel and cost. The aim of the present cost-effectiveness analysis (CEA) study performed from a societal perspective is to compare costs and consequences of caries preventive programs in a caries high-risk population. By 'costs' is meant both treatment costs and costs contributed by the patient and the patient's family. Costs contributed by patients and their families consist of out-of-pocket expenses, transportation costs, and time. Conclusions are that it is important to consider the perspective from which a study is carried out. Costs contributed by the patient and the patient's family have a high impact on total costs for children and younger adolescents but decrease with time as the adolescents get older. The present study shows an incremental cost-effectiveness of 2043 SEK (8.54 SEK = 1 US dollar, December 1999) per averted decayed enamel and dentine missing and filled surface (DeMFS), of which treatment costs represent 1337 SEK using the unit cost for a nurse. This means a yearly cost of approximately 334 SEK.
Oscarson
N
N
Epidemiology, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden. nils.oscarson@parodont.ftv.lul.se
Källestål
C
C
Fjelddahl
A
A
Lindholm
L
L
D000293:Adolescent; D000704:Analysis of Variance; D002327:Cariostatic Agents / Q000191:economics / Q000627:therapeutic use; D002648:Child; D017046:Cost Savings; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D004245:DMF Index; D003731:Dental Caries / Q000191:economics / Q000517:prevention & control*; D003733:Dental Caries Susceptibility; D003743:Dental Enamel / Q000473:pathology; D003804:Dentin / Q000473:pathology; D005382:Financing, Personal; D005459:Fluorides / Q000191:economics / Q000627:therapeutic use; D017048:Health Care Costs; D006801:Humans; D011313:Preventive Dentistry / Q000191:economics; D013548:Sweden; D013997:Time Factors; D014187:Transportation of Patients / Q000191:economics
D002327:Cariostatic Agents; D005459:Fluorides